Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
boston blog main
boston top stories
3
×
life sciences
national blog main
biotech
national top stories
agios therapeutics
aldehyde
aldeyra therapeutics
allergic conjunctivitis
base editing
biopharma
branden moriarty
broad institute
cas13
clinical trials
crispr therapeutics
crispr-cas9
david liu
deals
dna
drugs
dry eye disease
duchenne
editas medicine
editor
editr
enzyme
europe blog main
europe top stories
feng zhang
gene editing
harvard university
intellia therapeutics
john evans
keith joung
licensing
m&a
massachusetts general hospital
What
medicine
3
×
therapeutics
3
×
fda
gene
puts
aldeyra
approval
beam
betting
billion
biopharma
cas
closer
crispr
data
deal
disclosed
drug
duchenne
editas
editing
editor
eye
fighting
filing
founders
gotten
harvard
historic
inflammation
jump
mass
multiple
new
phase
positive
precise
recently
results
rna
Language
unset
Current search:
therapeutics
×
medicine
×
" boston top stories "
×
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
5 years ago
New Data Puts Aldeyra One Step Closer to FDA Filing for Eye Drug
@xconomy.com
5 years ago
Beam Therapeutics Spotlights CRISPR 2.0 with Precise Gene Editor, $87M
